Sp1058
FAILURES AND SUCCESSES AMONG BIOIMARKERS FOR FUNCTIONAL DYSPEPSIA
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
YOUNG VERSUS OLD GUT: DISTINCT AGE-RELATED CHARACTERISTICS IN IRRITABLE BOWEL SYNDROME
Ageing seems to have a beneficial effect on irritable bowel syndrome (IBS) (Sperber et al. Gastroenterology 2021), and the odds of developing IBS are lower when age is above 50 years (Lovell & Ford CGH 2012). Older age may also affect symptom reporting and quality of life…
LOCAL GASTROINTESTINAL REACTIONS TO FOOD IN DGBI
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI)…
IS IT DYSPEPSIA OR GASTROPARESIS
Back by popular demand, the experts will share and debate the evidence and their approaches to chronic pain, defecatory disorders, dyspepsia. and gastroparesis…